Closing the sickle cell disease-related health equity gap The Lancet Haematology ++... ++

Closing the sickle cell disease-related health equity gap The Lancet Haematology https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00146-8/fulltext?dgcid=raven_jbs_etoc_email Jun 2026 Volume 13Number 6e353-e426 https://www.thelancet.com/journals/lanhae/issue/vol13no6/PIIS2352-3026(26)X2005-1 Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trial Prof Anthony Stein, MDa,b Send email to astein@coh.org ∙ Yan Wang, MSc ∙ Prof Monzr M Al Malki, MDa,b ∙ Ibrahim Aldoss, MDa,b ∙ Haris Ali, MDa,b ∙ Ahmed Aribi, MDa,b ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00014-1/abstract?dgcid=raven_jbs_etoc_feature_lanhae Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study Josephus L M van Rooij, MDa,b ∙ Peter H Wessels, MD PhDa ∙ Johanna M Niers, MD PhDc ∙ Jacoline E C Bromberg, MD PhDd ∙ Johanna M M Gijtenbeek, MD PhDe ∙ Rick van Haastert, MScf ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00098-0/abstract?dgcid=raven_jbs_etoc_feature_lanhae